Pediatrix Medical Group Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pediatrix Medical Group Inc 's ROA in the second quarter of 2026?
Pediatrix Medical Group Inc achieved a return on average assets (ROA) of 8.09 % in its second quarter of 2026, this is above MD's average return on assets of 1.35%.
Pediatrix Medical Group Inc s assets during the 12 months ending in the second quarter of 2026 are valued at $2 billion

However, within the Healthcare sector 115 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 764, from total ROA ranking in the first quarter of 2026 at 934.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	1.34 %	3.85 %	11.63 %	15.6 %	16.31 %
Y / Y Net Income Change	1.48 %	42.61 %	10.51 %	268.85 %	-
Net Income (TTM) in million	175	174	165	162	110
Return On Assets (TTM)	8.09 %	8.09 %	7.74 %	7.81 %	5.49 %
MD's Total Ranking	# 764	# 934	# 805	# 1130	# 2998
Total Assets (TTM) in million	2,130	2,070	2,247	2,199	2,102
Seq. Total Assets Change	2.9 %	-7.85 %	2.15 %	4.63 %	5.45 %
Seq. Net Income Change	34.73 %	-12.2 %	-53.03 %	82.65 %	89.32 %

MD's 5 Years Annual ROA >> Back to MD Management Effectiveness >> Compare MD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 12
Sector	# 116
Overall	# 758

Return On Assets Statistics
High	Average	Low
11.35 %	1.35 %	-48.01 %
(Jun 30 2011)		(Jun 30 2020)

Financial Statements
Pediatrix Medical Group Inc 's Assets	$ 2,130 million	MD's Balance sheet
Pediatrix Medical Group Inc 's Income	$ 40 million	Quarterly MD's Income Statement
MD's Income by Division		See MD's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	11.63 %	-1.78 %	-5.91 %	-20.01 %	-18.68 %
Total Assets in million	2,247	2,013	2,049	2,178	2,723
Y / Y Net Income Change	-	-	-	-49.34 %	-
Net Income in million	165	-99	-60	66	131
Annual Return On Assets	7.36 %	-4.92 %	-2.95 %	3.05 %	4.81 %

MD's 5 Years Annual ROA >> Back to MD Management Effectiveness >> Compare MD ROA to its Competitors

Comment on MD's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 7.36 % compared to prior year, due to annual net income growth of % to $165.39 million, while value of Pediatrix Medical Group Inc 's overall assets grew just by 11.63 % to $2,246.70 million, compared to $2,246.70 a year before.

More Return On Assets Ratios
MD's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MD's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MD's Competitors
Subscribers only: Roa for Pediatrix Medical Group Inc 's Suppliers
Subscribers only: Return On Assets for MD's Customers

You may also want to know
MD's Roi	MD's Inventory Turnover Ratio	MD's Growth Rates	MD's Dividend Comparisons
	MD's Profitability Ratios	MD's Asset Turnover Ratio	MD's Dividend Growth
MD's Roe	MD's Valuation Ratios	MD's Financial Strength Ratios	MD's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %

Date modified: 2026-08-31T04:23:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.